Clio Formulations Private Limited
About Clio Formulations Private Limited
Data last updated:
Clio Formulations Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U93000UP2020PTC129267. Its GSTIN is 09AAICC7442F1ZK (Uttar Pradesh).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Sunil Venkateshwar (Whole-Time Director) and Sushma Dixit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 133/82 Block 'O' Kidwai Nagar, Kanpur, Uttar Pradesh, India – 208011.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.88 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.97 Lakh (net margin 9.5%) and EBITDA of ₹3.11 Lakh (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 128% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address133/82 Block 'O' Kidwai Nagar, Kanpur, Uttar Pradesh, India – 208011
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Clio Formulations Private Limited
The main business activity of Clio Formulations is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Clio Formulations Private Limited FY 2025 filings available
Clio Formulations Private Limited reported revenue of ₹20.88 Lakh (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Clio Formulations Private Limited
Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 128%. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Clio Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.11 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.97 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Clio Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 14.9% | •••• | •••• | •••• |
| Net Profit Margin | 9.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clio Formulations are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Clio Formulations Private Limited
Clio Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushma Dixit | Director | 09 Jul 2021 | 5 Years 3 Months | Current |
| Sonal | Director | 10 Dec 2020 | 5 Years 10 Months | Current |
| Sunil Venkateshwar | Whole-Time Director | 08 Jun 2020 | 6 Years 4 Months | Current |
Peer Comparison of Clio Formulations Private Limited
Clio Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vinkem Labs Limited | ₹20.97 Lakh (FY 2017) | •••• | •••• | 44.0% | •••• | Chennai, Tamil Nadu, India |
| Valnac (OPC) Private Limited | ₹20.94 Lakh (FY 2024) | •••• | •••• | •••• | Kasauli, Himachal Pradesh, India | |
| Zibran Pharmaceuticals Private Limited | ₹20.93 Lakh (FY 2024) | •••• | •••• | -76.0% | •••• | Godhra, Gujarat, India |
| Lan Pharma Chem Private Limited. | ₹20.93 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Delhi, India |
| Zentiva Healthcare Private Limited | ₹20.9 Lakh (FY 2022) | •••• | •••• | 36.0% | •••• | Chennai, Tamil Nadu, India |
| Clio Formulations Private Limited this company | ₹20.88 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Kanpur, Uttar Pradesh, India |
| AA Hygiene & Health Care Films Private Limited | ₹20.84 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Dombivli East, Maharashtra, India |
| Kishri Pharma Private Limited | ₹20.75 Lakh (FY 2024) | •••• | •••• | -37.0% | •••• | Deoghar, Jharkhand, India |
| Vivamed Pharmaceuticals Private Limited | ₹20.74 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Hemanagar, Uppal, Telangana, India |
| Alvitas Pharmaceuticals Private Limited | ₹20.7 Lakh (FY 2021) | •••• | •••• | •••• | Upper Bazar, Ranchi, Jharkhand, India | |
| Rymph India Biotech Private Limited | ₹20.67 Lakh (FY 2024) | •••• | •••• | -75.0% | •••• | Greater Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Clio Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Clio Formulations Private Limited
Clio Formulations Private Limited is audited by J.K. SARAWGI @ CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J.K. SARAWGI @ CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Clio Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Clio Formulations Private Limited
Clio Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Clio Formulations Private Limited
Clio Formulations Private Limited has a workforce of 0 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Clio Formulations Private Limited
Clio Formulations Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Sushma Dixit was appointed as Director on 09 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for Clio Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Clio Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Clio Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Clio Formulations Private Limited
Clio Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC7442F1ZK | Uttar Pradesh | Active | 16 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Clio Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clio Formulations Private Limited
Clio Formulations is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2020 (6+ years old) and is registered under CIN U93000UP2020PTC129267.
Clio Formulations reported revenue of ₹20.88 Lakh for FY 2024 (down 8% YoY).
Clio Formulations has 3 current directors:
- Sunil Venkateshwar - Whole-Time Director
- Sushma Dixit - Director
- Sonal - Director
Clio Formulations reported a net profit of ₹1.97 Lakh (net margin 9.5%) and EBITDA of ₹3.11 Lakh (EBITDA margin 14.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Clio Formulations is 128% over three years. In the latest year (FY 2024) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Clio Formulations is 09AAICC7442F1ZK, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Clio Formulations is U93000UP2020PTC129267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clio Formulations was incorporated on 08 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Clio Formulations by revenue are Vinkem Labs Limited, Valnac (OPC) Private Limited, Zibran Pharmaceuticals Private Limited, Lan Pharma Chem Private Limited, Zentiva Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Sushma Dixit was appointed as Director on 09 Jul 2021. Sunil Kumar Dixit ceased to be Whole-Time Director on 06 Jul 2021. Sonal was appointed as Director on 10 Dec 2020. Clio Formulations has 4 board changes on record in total.
The registered office of Clio Formulations is at 13382 Block O Kidwai Nagar, Kanpur, Uttar Pradesh, India – 208011.